Cryoablation and Immunotherapy: An Enthralling Synergy for Cancer Treatment
- PMID: 37232823
- PMCID: PMC10217386
- DOI: 10.3390/curroncol30050365
Cryoablation and Immunotherapy: An Enthralling Synergy for Cancer Treatment
Abstract
As less invasive options for surgical tumor removal, minimally invasive ablative techniques have gained popularity. Several solid tumors are being treated with cryoablation, a non-heat-based ablation technique. Cryoablation data in comparison over time demonstrates better tumor response and faster recovery. Combining cryosurgery with other cancer therapies has been explored to improve the cancer-killing process. Cryoablation with the combination of immunotherapy, results in a robust and efficient attack on the cancer cells. This article focuses on investigating the ability of cryosurgery to create a strong antitumor response when combined with immunologic agents resulting in a synergetic effect. To achieve this objective, we combined cryosurgery with immunotherapy using Nivolumab and lpilimumab. Five clinical cases of lymph node, lung cancer, bone, and lung metastasis were followed and analyzed. In this series of patients, percutaneous cryoablation and addressing immunity agents were technically feasible. In the follow-ups, there appeared to be no radiological evidence of new tumor development.
Keywords: cancer; cryosurgery; immunity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures











Similar articles
-
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors.Front Immunol. 2019 Sep 24;10:2283. doi: 10.3389/fimmu.2019.02283. eCollection 2019. Front Immunol. 2019. PMID: 31608067 Free PMC article. Review.
-
Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review.J Thorac Oncol. 2018 May;13(5):624-635. doi: 10.1016/j.jtho.2018.01.017. Epub 2018 Jan 31. J Thorac Oncol. 2018. PMID: 29391289 Review.
-
Cancer immunotherapy using tumor cryoablation.Immunotherapy. 2014;6(1):85-93. doi: 10.2217/imt.13.151. Immunotherapy. 2014. PMID: 24341887 Review.
-
An update on the use of cryoablation and immunotherapy for breast cancer.Front Immunol. 2022 Oct 27;13:1026475. doi: 10.3389/fimmu.2022.1026475. eCollection 2022. Front Immunol. 2022. PMID: 36389815 Free PMC article. Review.
-
Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.Theranostics. 2022 Feb 14;12(5):2175-2204. doi: 10.7150/thno.67530. eCollection 2022. Theranostics. 2022. PMID: 35265206 Free PMC article. Review.
Cited by
-
Cutting-Edge Therapies for Lung Cancer.Cells. 2024 Mar 1;13(5):436. doi: 10.3390/cells13050436. Cells. 2024. PMID: 38474400 Free PMC article. Review.
-
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors.Biomark Res. 2025 Feb 26;13(1):35. doi: 10.1186/s40364-025-00748-4. Biomark Res. 2025. PMID: 40012016 Free PMC article. Review.
-
Percutaneous Intratumoral Immunoadjuvant Gel Increases the Abscopal Effect of Cryoablation for Checkpoint Inhibitor Resistant Cancer.Adv Healthc Mater. 2024 Mar;13(6):e2301848. doi: 10.1002/adhm.202301848. Epub 2023 Nov 30. Adv Healthc Mater. 2024. PMID: 37870153 Free PMC article.
-
Application of cryoablation in animal models of bladder and muscle-invasive bladder cancer: a narrative review of current status and future perspectives.Quant Imaging Med Surg. 2024 Dec 5;14(12):9653-9666. doi: 10.21037/qims-24-1174. Epub 2024 Nov 12. Quant Imaging Med Surg. 2024. PMID: 39698593 Free PMC article. Review.
-
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation.Liver Cancer. 2025 Jun 19. doi: 10.1159/000546765. Online ahead of print. Liver Cancer. 2025. PMID: 40686658 Free PMC article.
References
-
- Siegel R.L., Miller K.D., Jemal A. Cancer Statistics. Cancer Surg. 2018;68:7–30. - PubMed
-
- Barnestein R., Galland L., Kalfeist L., Ghiringhelli F., Ladoire S., Limagne E. Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness. Oncoimmunology. 2022;11:2120676. doi: 10.1080/2162402X.2022.2120676. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials